BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22938530)

  • 1. Acquired epidermodysplasia verruciformis in a child with atopic dermatitis.
    Fernandez KH; Rady P; Tyring S; Stone MS
    Pediatr Dermatol; 2014; 31(3):400-2. PubMed ID: 22938530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful symptomatic treatment of epidermodysplasia verruciformis with imiquimod 5% cream].
    Heratizadeh A; Völker B; Kupsch E; Wichmann K; Kapp A; Werfel T
    Hautarzt; 2010 Dec; 61(12):1052-5. PubMed ID: 20824263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained clinical resolution of acquired epidermodysplasia verruciformis in an immunocompromised patient after discontinuation of oral acitretin with topical imiquimod.
    Nijhawan RI; Osei-Tutu A; Hugh JM
    J Drugs Dermatol; 2013 Mar; 12(3):348-9. PubMed ID: 23545921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermodysplasia verruciformis and human papilloma virus.
    Gewirtzman A; Bartlett B; Tyring S
    Curr Opin Infect Dis; 2008 Apr; 21(2):141-6. PubMed ID: 18317036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: a therapeutic challenge.
    Baskan EB; Tunali S; Adim SB; Turan A; Toker S
    J Dermatolog Treat; 2006; 17(3):179-83. PubMed ID: 16854762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.
    Berthelot C; Dickerson MC; Rady P; He Q; Niroomand F; Tyring SK; Pandya AG
    J Am Acad Dermatol; 2007 May; 56(5):882-6. PubMed ID: 17368633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifocal leiomyosarcomatosis in a 6-year-old child with epidermodysplasia verruciformis and immune defect.
    Boybeyi O; Akçören Z; Oğuz B; Akyüz C; Sanal O; Ergin S; Ersoy-Evans S; Tanyel FC
    J Pediatr Surg; 2009 Jul; 44(7):e5-8. PubMed ID: 19573649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired epidermodysplasia verruciformis in an HIV-positive patient.
    Lau C; Acharya S; Arumainayagam JT; Kasparis C; Dhesi I
    Int J STD AIDS; 2016 Oct; 27(11):1023-5. PubMed ID: 26516132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermodysplasia verruciform-like Lesions in an HIV patient.
    Berk DR; Bruckner AL; Lu D
    Dermatol Online J; 2009 Jan; 15(1):1. PubMed ID: 19281706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the evidence for effective treatments of acquired epidermodysplasia verruciformis in HIV-infected patients?
    Lee KC; Risser J; Bercovitch L
    Arch Dermatol; 2010 Aug; 146(8):903-5. PubMed ID: 20713825
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate.
    Kim C; Hashemi P; Caglia M; Shulman K
    J Drugs Dermatol; 2016 Mar; 15(3):350-2. PubMed ID: 26954321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eccrine Syringofibroadenoma in Association With Acquired Epidermodysplasia Verruciformis.
    Tan T; Guitart J; Liu LL; Brieva JC; Amin S; Rani M; Gerami P; Yazdan P
    Am J Dermatopathol; 2017 Jul; 39(7):534-537. PubMed ID: 28346303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired Human Papilloma Virus Type 6-Associated Epidermodysplasia Verruciformis in a Patient With Systemic Lupus Erythematosus.
    Ferronika P; Sijmons RH; Febiyanto N; Radiono S; Widodo I
    Am J Dermatopathol; 2020 Nov; 42(11):e156-e158. PubMed ID: 32675468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermodysplasia verruciformis: successful treatment with squaric acid dibutylester.
    Kehdy J; Erickson C; Rady P; Tyring S; Gaspari AA
    Cutis; 2015 Aug; 96(2):114-8. PubMed ID: 26367749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen presentation and T-cell activation in epidermodysplasia verruciformis.
    Cooper KD; Androphy EJ; Lowy D; Katz SI
    J Invest Dermatol; 1990 Jun; 94(6):769-76. PubMed ID: 2162366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired Epidermodysplasia Verruciformis Associated with Human Papilloma Virus Type 14 in a Small Bowel Transplanted Child--A Case Report.
    Hirschman D; Tacastacas J; Rady PL; Tyring SK; Cooper K; Honda K
    Pediatr Dermatol; 2016; 33(1):e1-5. PubMed ID: 26646304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermodysplasia verruciformis: unsuccessful therapeutic approach with imiquimod.
    Janssen K; Lucker GP; Houwing RH; van Rijssel R
    Int J Dermatol; 2007 Nov; 46 Suppl 3():45-7. PubMed ID: 17973891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidermodysplasia verruciformis: about a case].
    Agharbi FZ
    Pan Afr Med J; 2018; 30():78. PubMed ID: 30344862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination.
    Maor D; Brennand S; Goh MS; Fahey V; Tabrizi SN; Chong AH
    Australas J Dermatol; 2018 May; 59(2):147-148. PubMed ID: 28718200
    [No Abstract]   [Full Text] [Related]  

  • 20. Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.
    Yoshida R; Kato T; Kawase M; Honda M; Mitsuishi T
    BMC Dermatol; 2014 Jul; 14():12. PubMed ID: 25048734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.